Skip to main content
Clinical Trials/CTRI/2022/06/043539
CTRI/2022/06/043539
Not yet recruiting
Phase 2

Pharmaceutical, Analytical and Clinical study of ââ?¬Å?Manjishthadi Tail and Manjishthadi Creamââ?¬? in the management of Yuvan Pidika.

IA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
IA
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
IA

Eligibility Criteria

Inclusion Criteria

  • 1 Patients having clinical sign and symptoms of yuvan pidika
  • 2 Patients between age group of (18\-30\) years of age.
  • 3 Patients willing to participate in trial.

Exclusion Criteria

  • 1 Patients suffering from chronic skin disease.
  • 2 Patients under long term steroids and cytotoxic treatments.
  • 3 Patients with evidence of malignancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
To study the effect of â??Dashemani Kandughna Gelâ?? local application in the management of Dandruff ( itching over scalp, Flakes on scalp etc)Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
CTRI/2020/12/030010Dr Nilima Sanjay Dharkar
Completed
Not Applicable
Clinical efficacy, saftey and pharmacodynamics of antifungal agents on chronic pulmonary mycosis
JPRN-UMIN000003108ational Hospital Organization, Tokyo National Hospital20
Completed
Phase 1
Efficacy and safety of Chinese herbal medicine (RCM-102) for treatment of seasonal allergic rhinitis (hayfever)seasonal allergic rhinitisInflammatory and Immune System - AllergiesRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Herbal remedies
ACTRN12612000209897Professor Charlie Xua104
Not yet recruiting
Phase 3
Clinical study of application shalmali kantak extract in the form of arka and gel form in pimples.Health Condition 1: L700- Acne vulgaris
CTRI/2024/07/069888Dr Indira V
Active, not recruiting
Phase 1
Clinical trial to evaluate the efficacy, safety and pharmacokinetics profile of nebulized Aztreonam Lysine (AZLI) for prevention of Gram negative pneumonia in heavily colonized mechanically ventilated patientsGram negative pneumonia in heavily colonized mechanically ventilated patientsMedDRA version: 20.0Level: LLTClassification code 10035725Term: Pneumonia NOSSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2018-003865-32-ESAlejandro Rodriguez Oviedo - Critical Care Department – Hospital Universitario de Tarragona Joan XXIII20